Examkin

Question

Difficulty: HardOrdering Imaging Studies

A 65-year-old woman presents to the outpatient clinic with a 3-week history of painless yellowing of her skin and eyes. She also reports a 5-kg (11-lb) unintentional weight loss, dark urine, and pale acholic stools. She has no significant past medical history. Vital signs are within normal limits. Physical examination reveals profound scleral icterus and a palpable, non-tender mass in the right upper quadrant. Laboratory studies show a total bilirubin of 10.2 mg/dL, direct bilirubin of 8.6 mg/dL, and an alkaline phosphatase of 750 U/L. A multidisciplinary tumor board anticipates she will require neoadjuvant chemotherapy followed by surgical resection, but notes that she is currently suffering from severe, intractable pruritus due to hyperbilirubinemia.

Arrange the following diagnostic and interventional modalities in the most appropriate chronological sequence for the evaluation and management of this patient, from the initial diagnostic step to the final therapeutic step.

  1. 1Transabdominal right upper quadrant ultrasonography
  2. 2Pancreatic protocol multiphasic computed tomography of the abdomen
  3. 3Endoscopic ultrasonography with fine-needle aspiration
  4. 4Endoscopic retrograde cholangiopancreatography with biliary stenting

Answer

The correct sequence is: 1) Transabdominal right upper quadrant ultrasonography, 2) Pancreatic protocol multiphasic computed tomography, 3) Endoscopic ultrasonography with fine-needle aspiration, 4) Endoscopic retrograde cholangiopancreatography with biliary stenting.
The patient's painless jaundice, weight loss, and Courvoisier sign (palpable, non-tender gallbladder) strongly suggest a periampullary malignancy, most likely pancreatic adenocarcinoma. The evidence-based sequencing of modalities minimizes patient risk and maximizes diagnostic yield. Transabdominal ultrasound is universally the first step to confirm ductal dilation. Once confirmed, a multiphasic pancreatic protocol CT is required to stage the tumor and determine surgical resectability. Crucially, this CT must be done before any invasive procedures like ERCP, as biliary stents cause artifact, and introduced air obscures vital vascular anatomy. After staging is complete, EUS is the preferred modality to obtain a tissue biopsy (FNA) without the risk of peritoneal seeding associated with percutaneous biopsies. Finally, because the patient has intractable pruritus and is slated for neoadjuvant chemotherapy (meaning a delay before definitive surgical resection), ERCP with biliary stenting is performed to relieve the obstruction.

Step-by-Step Solution

1
Order transabdominal right upper quadrant ultrasonography.
Confirms intra- and extrahepatic biliary ductal dilation and the absence of radiopaque gallstones in the gallbladder.
Ultrasound is the highly sensitive, cost-effective, and non-invasive initial test of choice to evaluate painless jaundice and confirm an obstructive etiology.
2
Order a pancreatic protocol multiphasic computed tomography (CT) of the abdomen.
Identifies a suspected pancreatic head mass, evaluates for superior mesenteric artery or vein encasement, and screens for hepatic metastases.
Cross-sectional imaging must be performed prior to any invasive ductal manipulation (which can introduce air or alter tissue planes) to accurately stage the disease for resectability.
3
Perform endoscopic ultrasonography (EUS) with fine-needle aspiration (FNA).
Obtains a targeted tissue sample for histologic or cytologic analysis.
A definitive tissue diagnosis is required before initiating the planned neoadjuvant chemotherapy for pancreatic adenocarcinoma.
4
Perform endoscopic retrograde cholangiopancreatography (ERCP) with biliary stenting.
Decompresses the obstructed biliary tree, lowering serum bilirubin levels.
Therapeutic decompression is indicated because the patient has severe, intractable pruritus and requires neoadjuvant therapy prior to definitive surgical resection.

Key Concept

The diagnostic algorithm for suspected malignant biliary obstruction requires non-invasive confirmation (ultrasound), anatomic staging (multiphasic CT), tissue diagnosis (EUS-FNA), and finally therapeutic intervention (ERCP) if indicated for severe symptoms or delayed surgery.
Estimated Time:2m 0s
Rate this question

Topics

Ordering Imaging Studies

More questions from this topic